CN Patent
CN1514721A — 一日服用一次的羟考酮制剂
Assigned to Euro Celtique SA · Expires 2004-07-21 · 22y expired
What this patent protects
本发明涉及含有羟考酮或其药学上可接受的盐的持续释放制剂,它以稳态供患者口服后提供了约0.6-1.0或0.7-1的C 24 /C max 羟考酮比平均值,及其方法。
USPTO Abstract
本发明涉及含有羟考酮或其药学上可接受的盐的持续释放制剂,它以稳态供患者口服后提供了约0.6-1.0或0.7-1的C 24 /C max 羟考酮比平均值,及其方法。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.